Gemtuzumab ozogamicin with or without interleukin 11 in patients 65 years of age or older with untreated acute myeloid leukemia and high-risk myelodysplastic syndrome: comparison with idarubicin plus continuous-infusion, high-dose cytosine arabinosi (Q44010377)
Jump to navigation
Jump to search
scientific article published in June 2002
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Gemtuzumab ozogamicin with or without interleukin 11 in patients 65 years of age or older with untreated acute myeloid leukemia and high-risk myelodysplastic syndrome: comparison with idarubicin plus continuous-infusion, high-dose cytosine arabinosi |
scientific article published in June 2002 |
Statements
1 reference
Gemtuzumab ozogamicin with or without interleukin 11 in patients 65 years of age or older with untreated acute myeloid leukemia and high-risk myelodysplastic syndrome: comparison with idarubicin plus continuous-infusion, high-dose cytosine arabinosi (English)
1 reference
Hagop M Kantarjian
1 reference
Jorge E Cortes
1 reference
Elihu H Estey
1 reference
Francis J Giles
1 reference
Peter F Thall
1 reference
Xue-Mei Wang
1 reference
Miloslav Beran
1 reference
Sherry A Pierce
1 reference
Deborah A Thomas
1 reference
1 June 2002
1 reference
Identifiers
1 reference